Clinical trial

Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus

NCT01030679

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention CKD-501 0.5mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention CKD-501 1mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention CKD-501 2mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-07-01

PhasePHASE2

Conditions

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Interventions

CKD-501 0.5mgDRUG

CKD-501 1mgDRUG

CKD-501 2mgDRUG

PlaceboDRUG

Sponsors & collaborators

Chong Kun Dang Pharmaceuticallead sponsor

Mapped research locations

SeoulSouth Korea3 DaeguSouth Korea1 BusanSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01030679 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.